BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 33157161)

  • 1. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
    Thomas D; Rathinavel AK; Radhakrishnan P
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
    Sethi MK; Fanayan S
    Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue.
    Ruhaak LR; Taylor SL; Stroble C; Nguyen UT; Parker EA; Song T; Lebrilla CB; Rom WN; Pass H; Kim K; Kelly K; Miyamoto S
    J Proteome Res; 2015 Nov; 14(11):4538-49. PubMed ID: 26322380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomics hits the big time.
    Hart GW; Copeland RJ
    Cell; 2010 Nov; 143(5):672-6. PubMed ID: 21111227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.
    Wang M; Zhu J; Lubman DM; Gao C
    Clin Chem Lab Med; 2019 Mar; 57(4):407-416. PubMed ID: 30138110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
    Taniguchi N; Kizuka Y
    Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical approaches to perturb, profile, and perceive glycans.
    Agard NJ; Bertozzi CR
    Acc Chem Res; 2009 Jun; 42(6):788-97. PubMed ID: 19361192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
    Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
    Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases.
    Akiyoshi S; Iwata M; Berenger F; Yamanishi Y
    Mol Inform; 2020 Jan; 39(1-2):e1900112. PubMed ID: 31622036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosyltransferases as versatile tools to study the biology of glycans.
    Kofsky JM; Babulic JL; Boddington ME; De León González FV; Capicciotti CJ
    Glycobiology; 2023 Dec; 33(11):888-910. PubMed ID: 37956415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems Glycobiology: Integrating Glycogenomics, Glycoproteomics, Glycomics, and Other 'Omics Data Sets to Characterize Cellular Glycosylation Processes.
    Bennun SV; Hizal DB; Heffner K; Can O; Zhang H; Betenbaugh MJ
    J Mol Biol; 2016 Aug; 428(16):3337-3352. PubMed ID: 27423401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
    Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
    Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of O-glycosylation in human disease.
    Magalhães A; Duarte HO; Reis CA
    Mol Aspects Med; 2021 Jun; 79():100964. PubMed ID: 33775405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycomics approach to the discovery of potential cancer biomarkers.
    An HJ; Lebrilla CB
    Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
    Miura Y; Endo T
    Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protein glycosylation in cancer metastasis.
    Oliveira-Ferrer L; Legler K; Milde-Langosch K
    Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Enzymatic Assembly of a Comprehensive 64-Membered IgG N-Glycan Library for Functional Glycomics.
    Ma W; Xu Z; Jiang Y; Liu J; Xu D; Huang W; Li T
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303832. PubMed ID: 37632720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.